Natural Selection and Population History in the Human Angiotensinogen Gene (AGT): 736 Complete AGT Sequences in Chromosomes from Around the World

American Journal of Human Genetics

Volumn 74, Issue 5, 2004, Pages 898-916

  Nakajima, Toshiaki ^a   Wooding, Stephen ^c   Sakagami, Takuro ^a   Emi, Mitsuru ^d   Tokunaga, Katsushi ^b   Tamiya, Gen ^e   Ishigami, Tomoaki ^f   Umemura, Satoshi ^f   Munkhbat, Batmunkh ^e,g   Jin, Feng ^h   Guan Jun, Jia ⁱ   Hayasaka, Ikuo ^j   Ishida, Takafumi ^a   Saitou, Naruya ^k   Pavelka, Karel ^l   Lalouel, Jean Marc ^c   Jorde, Lynn B ^c   Inoue, Ituro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d NIPPON MEDICAL SCHOOL   (Japan)

^e TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f YOKOHAMA CITY UNIVERSITY   (Japan)

^g Institute of Veterinary Medicine   (Mongolia)

^h INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

ⁱ Harbin Red Cross Blood Center   (China)

^j SANWA KAGAKU KENKYUSHO CO LTD   (Japan)

^k NATIONAL INSTITUTE OF GENETICS   (Japan)

^l INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN;

AFRICA; AGT GENE; ARTICLE; CARDIOVASCULAR RISK; CHROMOSOME; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HUMAN; HYPERTENSION; HYPOTHESIS; MAJOR CLINICAL STUDY; NATURAL SELECTION; NUCLEOTIDE SEQUENCE; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION;

EID: 2342459066     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/420793     Document Type: Article

References (36)

1. Bamshad MJ, Wooding S (2003) Signatures of natural selection in the human genome. Nat Rev Genet 4:99-111
2. Burt VL, Whelton P, Roccella EG, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D (1995) Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey 1988-1991. Hypertension 25:305-313
3. Corvol P, Jeunemaitre X (1997) Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev 18:662-677
4. Fay JC, Wu CI (2000) Hitchhiking under positive Darwinian selection. Genetics 155:1405-1413
5. Felsenstein J (1989) PHYLIP: Phylogeny Inference Package (version 3.2). Cladistics 5:164-166
6. Fu YX, Li WH (1993) Statistical tests of neutrality of mutations. Genetics 133:693-709
7. Gleiberman L (1973) Blood pressure and dietary salt in human populations. Ecol Food Nutr 2:143-156
8. Harpending H, Rogers A (2000) Genetic perspectives on human origins and differentiation. Annu Rev Genomics Hum Genet 1:361-385
9. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM (1997) A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786-1797
10. Jeunemaitre X, Soubrier F, Kotelevstev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71:169-180
11. Kaplan NL, Lewis PO, Weir BS (1994) Age of the ΔF508 cystic fibrosis mutation. Nat Genet 8:216-217
12. Kimura M, Ohta T (1973) The age of a neutral mutant persisting in a finite population. Genetics 75:199-212
13. Lewontin RC (1964) The interaction of selection and linkage. I. General considerations, heterotic models. Genetics 49:49-67
14. Lifton RP (1996) Molecular genetics of human blood pressure variation. Science 272:676-680
15. Luft FC (2001) Molecular genetics of salt-sensitivity and hypertension. Drug Metab Dispos 29:500-504
16. Menard J, El Amrani A-I, Savoie F, Bouhnik J (1991) Angiotensinogen: an attractive and underrated participant in hypertension and inflammation. Hypertension 18:705-706
17. Nakajima T, Jorde LB, Ishigami T, Umemura S, Emi M, Lalouel J-M, Inoue I (2002) Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet 70:108-123
18. Nei M (1987) Molecular evolutionary genetics. Columbia University Press, New York
19. Reich DE, Schaffner SF, Daly MJ, McVean G, Mullikin JC, Higgins JM, Richter DJ, Lander ES, Altshuler D (2002) Human genome sequence variation and the influence of gene history, mutation and recombination. Nat Genet 32:135-142
20. Rogers AR (1997) Population structure and modern human origins. In: Donnelly PJ, Tavare S (eds) Progress in population genetics and human evolution. Springer-Verlag, New York, pp 55-79
21. Rozas J, Rozas R (1999) DnaSP version 3: an integrated program for molecular population genetics and molecular evolution analysis. Bioinformatics 15:174-175
22. Sabeti PC, Reich DE, Higgins JM, Levine HZ, Richter DJ, Schaffner DF, Gabriel SB, Platko JV, Patterson NJ, McDonald GJ, Ackerman HC, Campbell SJ, Altshuler D, Cooper R, Kwiatowski D, Ward R, Lander ES (2002) Detecting recent positive selection in the human genome from haplotype structure. Nature 419:832-837
23. Schneider S, Kueffer J-M, Roesslie D, Excoffier L (2000) Arlequin: a software for population genetic data analysis. University of Geneva, Geneva
24. Sealey JE, Laragh JH (1990) The rennin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis and management. Raven Press, New York, pp 1287-1317
25. Smithies O, Kim HS (1994) Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Nat Acad Sci USA 91:3612-3615
26. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C, et al (1998) Dating the origin of the CCR5-Δ32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 62:1507-1515
27. Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585-595
28. Takahashi N, Smithies O (1999) Gene targeting approaches to analyzing hypertension. J Am Soc Nephrol 10:1598-1605
29. Tishkoff SA, Dietzsch E, Speed W, Pakstis AJ, Kidd JR, Cheung K, Bonne-Tamir B, Santachiara-Benerecetti AS, Moral P, Krings M (1996) Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science 271: 1380-1387
30. Tishkoff SA, Verrelli BC (2003) Patterns of human genetic diversity: implications for human evolutionary history and disease. Annu Rev Genomics Hum Genet 4:293-340
31. Toomajian C, Kreitman M (2002) Sequence variation and haplotype structure at the human HFE locus. Genetics 161:1609-1623
32. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton, RP, Lalouel JM (1993) A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 4:59-61
33. Watkins WS, Rogers AR, Ostler CT, Wooding S, Bamshad MJ, Brassington AM, Carroll ML, Nguyen SV, Walker JA, Prasad BVR, Reddy PG, Das PK, Batzer MA, Jorde LB (2003) Genetic variation among world populations: inferences from 100 Alu insertion polymorphisms. Genome Res 17:1607-1618
34. Watterson GA (1975) On the number of segregating sites in genetical models without recombination. Theor Popul Biol 7: 256-276
35. Wooding S, Rogers AR (2002) The matrix coalescent and an application to single-nucleotide polymorphisms. Genetics 161:1641-1650
36. Wooding SP, Watkins WS, Bamshad MJ, Dunn DM, Weiss RB, Jorde LB (2002) DNA sequence variation in a 3.7-kb non-coding sequence 5′ of the CYP1A2 gene: implications for human population history and natural selection. Am J Hum Genet 71:528-542